News from nucleix A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Feb 21, 2019, 07:30 ET Nucleix's Non-Invasive Bladder EpiCheck™ Biomarker Test Allows for Personalized Monitoring of Bladder Cancer

Nucleix Ltd., a leading cancer detection and screening company, announced today that Bladder EpiCheck™, its biomarker-based non-invasive urine test...


Jan 30, 2019, 06:30 ET Nucleix's Bladder EpiCheck™, Urine Test for Monitoring Bladder Cancer, Chosen as Standard-of-Care by Radboud University Medical Center

Nucleix Ltd., a leading cancer detection and screening company, announced today that Radboud University Medical Center (UMC) in Nijmegen, the...


Jan 23, 2019, 07:30 ET Nucleix Announces Initial Positive Results in Detection of Upper Tract Urothelial Carcinoma With Its Bladder EpiCheck Urine Test

Nucleix Ltd., a leading cancer detection and screening company, announced today preliminary results from an ongoing prospective, single-center study, ...


Sep 06, 2018, 07:10 ET Nucleix Announces Positive Clinical Results for Lung EpiCheck in Early Detection of Lung Cancer

Nucleix Ltd., a leading cancer detection company, announced today positive results from a clinical study designed to evaluate its innovative Lung...


Jul 30, 2018, 06:00 ET Nucleix Receives €2.5 Million in Funding from the European H2020 / EIC pilot SME Instrument Programme, for Its Lung Cancer Diagnostic Tool

Nucleix Ltd., a leading cancer detection and screening company, announced today that it has received €2.5 million in funding, following its...


Jul 24, 2018, 06:00 ET Nucleix Announces Publication of Non-Invasive Bladder Cancer Recurrence Detection Study Showing Best-in-Class Performance

Nucleix Ltd., a leading cancer detection and screening company, announced today that the multi-center European study results with its Bladder...


Mar 26, 2018, 09:00 ET Leading European Bladder Cancer Experts: The Bladder EpiCheck Urine Test Can Reduce Invasive Procedures

Nucleix, an innovative cancer detection and screening company, announced today that their first product Bladder EpiCheck was presented in a special...


Mar 26, 2018, 04:00 ET D'après des experts européens de premier plan dans le domaine du cancer de la vessie, le test d'urine Bladder EpiCheck de Nucleix peut réduire les procédures invasives

Bladder EpiCheck™, un test d'urine novateur, a été présenté lors de la réunion annuelle de l'Association européenne d'urologie (EAU) à Copenhague, au ...


Mar 26, 2018, 04:00 ET El Nucleix Bladder EpiCheck Urine Test puede reducir los procedimientos invasivos

Principales expertos europeos en cáncer de vejiga: El Nucleix Bladder EpiCheck Urine Test puede reducir los procedimientos invasivos Bladder...


Mar 26, 2018, 04:00 ET I principali esperti europei del cancro alla vescica dichiarano: il test delle urine Bladder EpiCheck di Nucleix può ridurre le procedure invasive

Bladder EpiCheck™, un nuovo test delle urine, è stato presentato durante il meeting annuale dell'Associazione europea di urologia (EAU), il più...


Mar 26, 2018, 04:00 ET Führende europäische Blasenkrebsexperten: der Urintest Bladder EpiCheck von Nucleix kann invasive Verfahren reduzieren

Bladder EpiCheck™, ein neuartiger Urintest, wurde bei der Jahreskonferenz der European Association of Urology (EAU) in Kopenhagen, Dänemark, dem...


Mar 14, 2018, 08:00 ET Nucleix Announces its Bladder EpiCheck™ Availability on the QIAGEN Rotor-Gene Q Platform

Nucleix, an innovative cancer detection and screening company, announced today the compatibility of its Bladder EpiCheck with the Rotor-Gene Q...


Mar 22, 2017, 08:00 ET CE Mark Granted to Nucleix's Bladder EpiCheck - Announcing Superior Results Over All Other Non-Invasive Tests in a European Multi-Center Study for Bladder Cancer Monitoring

The company will present its new results during the European Association of Urology (EAU) annual meeting in London (March 24th - 28th) Nucleix, an...